...
首页> 外文期刊>Molecular and Cellular Endocrinology >Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma
【24h】

Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma

机译:遗传性和散发性甲状腺髓样癌中的10号染色体和RET基因拷贝数变化

获取原文
获取原文并翻译 | 示例

摘要

About 30% of hereditary Medullary Thyroid Carcinoma (MTC) have been demonstrated to harbour imbalance between mutant and wild-type RET alleles.We studied the RET copy number alterations (RET CNA) in 65 MTC and their correlation with RET mutation and patients' outcome.Fluorescence in situ Hybridization and Real-time PCR revealed RET CNA in 27.7% MTC but only in a variable percentage of cells. In sporadic MTC, RET CNA were represented by chromosome 10 aneuploidy while in hereditary MTC by RET amplification. A significant higher prevalence of RET CNA was observed in RET mutated MTC (P=0.003). RET CNA was also associated to a poorer outcome (P=0.005). However, the multivariate analysis revealed that only RET mutation and advanced clinical stage correlated with the worst outcome.In conclusion, 30% MTC harbour RET CNA in variable percentage of cells suggesting cell heterogeneity. RET CNA can be considered a poor prognostic factor potentiating the poor prognostic role of RET mutation.
机译:已证明约30%的遗传性髓样甲状腺癌(MTC)在突变型和野生型RET等位基因之间存在失衡。我们研究了65个MTC中的RET拷贝数变化(RET CNA)及其与RET突变和患者预后的相关性荧光原位杂交和实时PCR显示RET CNA在27.7%MTC中,但仅在可变百分比的细胞中。在散发性MTC中,RET CNA以10号染色体非整倍性表示,而在遗传性MTC中,通过RET扩增。在RET突变的MTC中观察到RET CNA的患病率显着较高(P = 0.003)。 RET CNA也与较差的预后相关(P = 0.005)。然而,多变量分析显示,只有RET突变和临床晚期才与最差的结果相关。总之,有30%的MTC在可变百分比的细胞中含有RET CNA,提示细胞异质性。 RET CNA可以被认为是不良预后因素,可增强RET突变的不良预后作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号